Arkolith/Insider Trading/ANTX/Form 4

Readnour Robin Shane

DirectorAN2 Therapeutics, Inc. (ANTX) · full profile →Form 4 · filed Mar 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Disposed to issuer(D)24K——0
Mar 19, 2026Grant(A)21K——21K
Mar 19, 2026Disposed to issuer(D)21K——0
Mar 19, 2026Grant(A)24K——24K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-120200) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML